Enovacom and Stalis Join Forces to Unlock the Value of UK Health Data
Enovacom and Stalis have joined forces to help UK health and care providers breakdown the technical barriers of extracting and sharing patient data to create integrated care records that support better care outcomes and improvements in the patient experience.
Read more ...
Highland Marketing Advisory Board Responds to the NHS Long Term Plan
The first meeting of Highland Marketing's newly expanded advisory board discussed the NHS Long Term Plan and what will be needed to make it a success. Structural change, leadership, investment, spending on the right systems at the right level, and empowerment emerged as key themes.
Read more ...
Allscripts Appoints Vice President and Managing Director, EMEA
Allscripts (NASDAQ: MDRX) has appointed a new leader for its business in the UK while strengthening its focus on Europe, the Middle East and Africa. Richard Strong, who was Vice President, International Services, is taking up the new role of vice president and managing director, EMEA.
Read more ...
Merck Granted U.S. Patent for Novel Combination of Artificial Intelligence and Blockchain Technology
Merck, a leading science and technology company, today announced that it has been granted Patent No. US 10,193,695 by the United States Patent and Trademark Office (USPTO). The patent relates to the formation of 'crypto-objects', a novel security procedure linking Artificial Intelligence (AI) and blockchain technology.
Read more ...
Philips Once Again Recognized as a Top 100 Global Innovator
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, has again been named a Derwent Top 100 Global Innovator by Clarivate Analytics. Clarivate Analytics' Top 100 Global Innovators Report identifies the world's most innovative organizations, assessing each one on its ability to successfully develop valuable patented inventions that also have strong commercialization potential based on
Read more ...
Clinical Study Confirms Effectiveness of CardioSecur® in Pre-Clinical Deployment in Ambulances
The study "CardioSecur® in the preclinical setting - When time does matter" of the University of Heidelberg confirms the advantages of the mobile ECG in acute cases. This was demonstrated by applying CardioSecur during a period of more than 7 months in ambulances in the area of Heidelberg, Germany.
Read more ...
BIOTRONIK Announces First Enrollment in CRT-Next Study
BIOTRONIK has announced first enrollment in a multicenter study that aims to demonstrate that a two-lead cardiac resynchronization therapy (CRT) system with atrial sensing is at least as effective as a conventional three-lead system. BIOTRONIK's CRT-DX technology provides therapy through two ventricular leads and features a floating dipole for complete atrial diagnostics without an additional lead.
Read more ...